nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Epirubicin—thyroid cancer	0.232	0.519	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—thyroid cancer	0.215	0.481	CiPCiCtD
Etoposide—germ cell cancer—thyroid cancer	0.128	0.527	CtDrD
Etoposide—lung cancer—thyroid cancer	0.115	0.473	CtDrD
Etoposide—PTGS2—thyroid cancer	0.0688	1	CbGaD
Etoposide—TOP2A—Epirubicin—thyroid cancer	0.0207	0.117	CbGbCtD
Etoposide—ABCC6—Doxorubicin—thyroid cancer	0.0207	0.117	CbGbCtD
Etoposide—ABCC1—Vandetanib—thyroid cancer	0.0167	0.0941	CbGbCtD
Etoposide—ABCC10—Doxorubicin—thyroid cancer	0.0158	0.0891	CbGbCtD
Etoposide—UGT1A1—Sorafenib—thyroid cancer	0.0122	0.069	CbGbCtD
Etoposide—ABCC1—Epirubicin—thyroid cancer	0.0115	0.0648	CbGbCtD
Etoposide—ABCG2—Vandetanib—thyroid cancer	0.0112	0.063	CbGbCtD
Etoposide—TOP2A—Doxorubicin—thyroid cancer	0.011	0.0621	CbGbCtD
Etoposide—ABCC3—Doxorubicin—thyroid cancer	0.00994	0.0561	CbGbCtD
Etoposide—ABCC2—Sorafenib—thyroid cancer	0.00745	0.042	CbGbCtD
Etoposide—ABCG2—Sorafenib—thyroid cancer	0.00673	0.038	CbGbCtD
Etoposide—ABCC1—Doxorubicin—thyroid cancer	0.0061	0.0344	CbGbCtD
Etoposide—ABCC2—Doxorubicin—thyroid cancer	0.00452	0.0255	CbGbCtD
Etoposide—ABCG2—Doxorubicin—thyroid cancer	0.00408	0.023	CbGbCtD
Etoposide—CYP3A5—Sorafenib—thyroid cancer	0.00373	0.021	CbGbCtD
Etoposide—CYP2C8—Sorafenib—thyroid cancer	0.00359	0.0202	CbGbCtD
Etoposide—CYP1A2—Sorafenib—thyroid cancer	0.00278	0.0157	CbGbCtD
Etoposide—ABCB1—Sorafenib—thyroid cancer	0.00243	0.0137	CbGbCtD
Etoposide—CYP3A4—Vandetanib—thyroid cancer	0.00241	0.0136	CbGbCtD
Etoposide—ABCB1—Doxorubicin—thyroid cancer	0.00147	0.0083	CbGbCtD
Etoposide—CYP3A4—Sorafenib—thyroid cancer	0.00145	0.0082	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—thyroid cancer	0.000882	0.00498	CbGbCtD
Etoposide—GSTT1—neck—thyroid cancer	0.000861	0.0964	CbGeAlD
Etoposide—TOP2B—saliva-secreting gland—thyroid cancer	0.000494	0.0554	CbGeAlD
Etoposide—GSTT1—thyroid gland—thyroid cancer	0.00041	0.0459	CbGeAlD
Etoposide—GSTP1—neck—thyroid cancer	0.000397	0.0445	CbGeAlD
Etoposide—TOP2B—trachea—thyroid cancer	0.000381	0.0427	CbGeAlD
Etoposide—GSTT1—head—thyroid cancer	0.000363	0.0407	CbGeAlD
Etoposide—ABCC6—thyroid gland—thyroid cancer	0.000333	0.0372	CbGeAlD
Etoposide—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.000313	0.312	CbGdCrCtD
Etoposide—GSTP1—saliva-secreting gland—thyroid cancer	0.00031	0.0347	CbGeAlD
Etoposide—ABCC10—saliva-secreting gland—thyroid cancer	0.000309	0.0347	CbGeAlD
Etoposide—TOP2B—thyroid gland—thyroid cancer	0.000302	0.0338	CbGeAlD
Etoposide—ABCC6—head—thyroid cancer	0.000295	0.033	CbGeAlD
Etoposide—TOP2B—head—thyroid cancer	0.000268	0.03	CbGeAlD
Etoposide—GSTP1—trachea—thyroid cancer	0.000239	0.0268	CbGeAlD
Etoposide—ABCC10—trachea—thyroid cancer	0.000239	0.0267	CbGeAlD
Etoposide—TOP2A—thyroid gland—thyroid cancer	0.000222	0.0248	CbGeAlD
Etoposide—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.000205	0.204	CbGdCrCtD
Etoposide—ABCC3—thyroid gland—thyroid cancer	0.00019	0.0213	CbGeAlD
Etoposide—GSTP1—thyroid gland—thyroid cancer	0.000189	0.0212	CbGeAlD
Etoposide—ABCC10—thyroid gland—thyroid cancer	0.000189	0.0212	CbGeAlD
Etoposide—TOP2B—lymph node—thyroid cancer	0.000187	0.021	CbGeAlD
Etoposide—ABCG2—saliva-secreting gland—thyroid cancer	0.000181	0.0203	CbGeAlD
Etoposide—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.000179	0.178	CbGdCrCtD
Etoposide—ABCC1—trachea—thyroid cancer	0.000169	0.0189	CbGeAlD
Etoposide—ABCC3—head—thyroid cancer	0.000168	0.0189	CbGeAlD
Etoposide—GSTP1—head—thyroid cancer	0.000168	0.0188	CbGeAlD
Etoposide—TOP2A—lymph node—thyroid cancer	0.000138	0.0154	CbGeAlD
Etoposide—ABCC1—thyroid gland—thyroid cancer	0.000134	0.015	CbGeAlD
Etoposide—ABCC3—lymph node—thyroid cancer	0.000118	0.0132	CbGeAlD
Etoposide—GSTP1—lymph node—thyroid cancer	0.000117	0.0131	CbGeAlD
Etoposide—ABCC10—lymph node—thyroid cancer	0.000117	0.0131	CbGeAlD
Etoposide—PTGS1—trachea—thyroid cancer	0.000117	0.0131	CbGeAlD
Etoposide—PTGS2—trachea—thyroid cancer	0.000111	0.0125	CbGeAlD
Etoposide—ABCG2—thyroid gland—thyroid cancer	0.000111	0.0124	CbGeAlD
Etoposide—CYP1A2—thyroid gland—thyroid cancer	0.000106	0.0119	CbGeAlD
Etoposide—Cardiac disorder—Sorafenib—thyroid cancer	0.000105	0.00258	CcSEcCtD
Etoposide—Decreased appetite—Vandetanib—thyroid cancer	0.000103	0.00255	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000102	0.00253	CcSEcCtD
Etoposide—Fatigue—Vandetanib—thyroid cancer	0.000102	0.00253	CcSEcCtD
Etoposide—Angiopathy—Sorafenib—thyroid cancer	0.000102	0.00252	CcSEcCtD
Etoposide—Immune system disorder—Sorafenib—thyroid cancer	0.000102	0.00251	CcSEcCtD
Etoposide—Rigors—Epirubicin—thyroid cancer	0.000102	0.00251	CcSEcCtD
Etoposide—Mediastinal disorder—Sorafenib—thyroid cancer	0.000102	0.00251	CcSEcCtD
Etoposide—Constipation—Vandetanib—thyroid cancer	0.000102	0.00251	CcSEcCtD
Etoposide—Pain—Vandetanib—thyroid cancer	0.000102	0.00251	CcSEcCtD
Etoposide—Alopecia—Sorafenib—thyroid cancer	9.96e-05	0.00246	CcSEcCtD
Etoposide—Necrosis—Doxorubicin—thyroid cancer	9.78e-05	0.00241	CcSEcCtD
Etoposide—Gastrointestinal pain—Vandetanib—thyroid cancer	9.71e-05	0.0024	CcSEcCtD
Etoposide—Dysgeusia—Sorafenib—thyroid cancer	9.61e-05	0.00237	CcSEcCtD
Etoposide—CYP2E1—thyroid gland—thyroid cancer	9.57e-05	0.0107	CbGeAlD
Etoposide—Extravasation—Epirubicin—thyroid cancer	9.51e-05	0.00235	CcSEcCtD
Etoposide—Cardiovascular disorder—Epirubicin—thyroid cancer	9.44e-05	0.00233	CcSEcCtD
Etoposide—Muscle spasms—Sorafenib—thyroid cancer	9.43e-05	0.00233	CcSEcCtD
Etoposide—ABCC2—lymph node—thyroid cancer	9.42e-05	0.0106	CbGeAlD
Etoposide—Rigors—Doxorubicin—thyroid cancer	9.4e-05	0.00232	CcSEcCtD
Etoposide—Body temperature increased—Vandetanib—thyroid cancer	9.38e-05	0.00232	CcSEcCtD
Etoposide—Abdominal pain—Vandetanib—thyroid cancer	9.38e-05	0.00232	CcSEcCtD
Etoposide—PTGS1—thyroid gland—thyroid cancer	9.22e-05	0.0103	CbGeAlD
Etoposide—Skin discolouration—Epirubicin—thyroid cancer	9.18e-05	0.00227	CcSEcCtD
Etoposide—Cellulitis—Epirubicin—thyroid cancer	9.12e-05	0.00225	CcSEcCtD
Etoposide—Anaemia—Sorafenib—thyroid cancer	9.07e-05	0.00224	CcSEcCtD
Etoposide—Hyperuricaemia—Epirubicin—thyroid cancer	8.94e-05	0.00221	CcSEcCtD
Etoposide—Extravasation—Doxorubicin—thyroid cancer	8.8e-05	0.00217	CcSEcCtD
Etoposide—Leukopenia—Sorafenib—thyroid cancer	8.78e-05	0.00217	CcSEcCtD
Etoposide—Ulcer—Epirubicin—thyroid cancer	8.77e-05	0.00216	CcSEcCtD
Etoposide—Cardiovascular disorder—Doxorubicin—thyroid cancer	8.73e-05	0.00216	CcSEcCtD
Etoposide—Loss of consciousness—Sorafenib—thyroid cancer	8.62e-05	0.00213	CcSEcCtD
Etoposide—Cough—Sorafenib—thyroid cancer	8.56e-05	0.00211	CcSEcCtD
Etoposide—Inflammation—Epirubicin—thyroid cancer	8.55e-05	0.00211	CcSEcCtD
Etoposide—Asthenia—Vandetanib—thyroid cancer	8.52e-05	0.0021	CcSEcCtD
Etoposide—Skin discolouration—Doxorubicin—thyroid cancer	8.5e-05	0.0021	CcSEcCtD
Etoposide—CYP2E1—head—thyroid cancer	8.49e-05	0.00951	CbGeAlD
Etoposide—Hypertension—Sorafenib—thyroid cancer	8.47e-05	0.00209	CcSEcCtD
Etoposide—Blood uric acid increased—Epirubicin—thyroid cancer	8.45e-05	0.00208	CcSEcCtD
Etoposide—Cellulitis—Doxorubicin—thyroid cancer	8.44e-05	0.00208	CcSEcCtD
Etoposide—Pruritus—Vandetanib—thyroid cancer	8.4e-05	0.00207	CcSEcCtD
Etoposide—ABCC1—lymph node—thyroid cancer	8.3e-05	0.00929	CbGeAlD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	8.3e-05	0.00205	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Epirubicin—thyroid cancer	8.29e-05	0.00205	CcSEcCtD
Etoposide—Hyperuricaemia—Doxorubicin—thyroid cancer	8.27e-05	0.00204	CcSEcCtD
Etoposide—PTGS1—head—thyroid cancer	8.18e-05	0.00916	CbGeAlD
Etoposide—Diarrhoea—Vandetanib—thyroid cancer	8.12e-05	0.002	CcSEcCtD
Etoposide—Ulcer—Doxorubicin—thyroid cancer	8.11e-05	0.002	CcSEcCtD
Etoposide—Anaphylactic shock—Sorafenib—thyroid cancer	8.01e-05	0.00198	CcSEcCtD
Etoposide—Infection—Sorafenib—thyroid cancer	7.95e-05	0.00196	CcSEcCtD
Etoposide—Skin exfoliation—Epirubicin—thyroid cancer	7.92e-05	0.00195	CcSEcCtD
Etoposide—Candida infection—Epirubicin—thyroid cancer	7.92e-05	0.00195	CcSEcCtD
Etoposide—Inflammation—Doxorubicin—thyroid cancer	7.91e-05	0.00195	CcSEcCtD
Etoposide—Dizziness—Vandetanib—thyroid cancer	7.85e-05	0.00194	CcSEcCtD
Etoposide—Thrombocytopenia—Sorafenib—thyroid cancer	7.84e-05	0.00194	CcSEcCtD
Etoposide—PTGS2—head—thyroid cancer	7.82e-05	0.00876	CbGeAlD
Etoposide—Blood uric acid increased—Doxorubicin—thyroid cancer	7.82e-05	0.00193	CcSEcCtD
Etoposide—Neuropathy—Epirubicin—thyroid cancer	7.79e-05	0.00192	CcSEcCtD
Etoposide—Skin disorder—Sorafenib—thyroid cancer	7.78e-05	0.00192	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	7.67e-05	0.00189	CcSEcCtD
Etoposide—Anorexia—Sorafenib—thyroid cancer	7.63e-05	0.00188	CcSEcCtD
Etoposide—Oesophagitis—Epirubicin—thyroid cancer	7.58e-05	0.00187	CcSEcCtD
Etoposide—Vomiting—Vandetanib—thyroid cancer	7.55e-05	0.00186	CcSEcCtD
Etoposide—Rash maculo-papular—Epirubicin—thyroid cancer	7.54e-05	0.00186	CcSEcCtD
Etoposide—Mouth ulceration—Epirubicin—thyroid cancer	7.5e-05	0.00185	CcSEcCtD
Etoposide—Rash—Vandetanib—thyroid cancer	7.48e-05	0.00185	CcSEcCtD
Etoposide—Dermatitis—Vandetanib—thyroid cancer	7.48e-05	0.00185	CcSEcCtD
Etoposide—Headache—Vandetanib—thyroid cancer	7.44e-05	0.00184	CcSEcCtD
Etoposide—Candida infection—Doxorubicin—thyroid cancer	7.33e-05	0.00181	CcSEcCtD
Etoposide—Skin exfoliation—Doxorubicin—thyroid cancer	7.33e-05	0.00181	CcSEcCtD
Etoposide—Neuropathy—Doxorubicin—thyroid cancer	7.21e-05	0.00178	CcSEcCtD
Etoposide—Sepsis—Epirubicin—thyroid cancer	7.2e-05	0.00178	CcSEcCtD
Etoposide—Dyspnoea—Sorafenib—thyroid cancer	7.14e-05	0.00176	CcSEcCtD
Etoposide—Nausea—Vandetanib—thyroid cancer	7.05e-05	0.00174	CcSEcCtD
Etoposide—Oesophagitis—Doxorubicin—thyroid cancer	7.01e-05	0.00173	CcSEcCtD
Etoposide—Phlebitis—Epirubicin—thyroid cancer	6.99e-05	0.00172	CcSEcCtD
Etoposide—Rash maculo-papular—Doxorubicin—thyroid cancer	6.98e-05	0.00172	CcSEcCtD
Etoposide—Decreased appetite—Sorafenib—thyroid cancer	6.96e-05	0.00172	CcSEcCtD
Etoposide—Mouth ulceration—Doxorubicin—thyroid cancer	6.94e-05	0.00171	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	6.92e-05	0.00171	CcSEcCtD
Etoposide—Gastrointestinal disorder—Sorafenib—thyroid cancer	6.91e-05	0.00171	CcSEcCtD
Etoposide—Fatigue—Sorafenib—thyroid cancer	6.9e-05	0.0017	CcSEcCtD
Etoposide—ABCB1—trachea—thyroid cancer	6.89e-05	0.00772	CbGeAlD
Etoposide—ABCG2—lymph node—thyroid cancer	6.87e-05	0.00769	CbGeAlD
Etoposide—Constipation—Sorafenib—thyroid cancer	6.85e-05	0.00169	CcSEcCtD
Etoposide—Pain—Sorafenib—thyroid cancer	6.85e-05	0.00169	CcSEcCtD
Etoposide—Sepsis—Doxorubicin—thyroid cancer	6.66e-05	0.00164	CcSEcCtD
Etoposide—Cardiac failure congestive—Epirubicin—thyroid cancer	6.64e-05	0.00164	CcSEcCtD
Etoposide—Gastrointestinal pain—Sorafenib—thyroid cancer	6.55e-05	0.00162	CcSEcCtD
Etoposide—Phlebitis—Doxorubicin—thyroid cancer	6.47e-05	0.0016	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	6.4e-05	0.00158	CcSEcCtD
Etoposide—Urticaria—Sorafenib—thyroid cancer	6.36e-05	0.00157	CcSEcCtD
Etoposide—Body temperature increased—Sorafenib—thyroid cancer	6.33e-05	0.00156	CcSEcCtD
Etoposide—Abdominal pain—Sorafenib—thyroid cancer	6.33e-05	0.00156	CcSEcCtD
Etoposide—Anaphylactoid reaction—Epirubicin—thyroid cancer	6.22e-05	0.00154	CcSEcCtD
Etoposide—Cardiac failure—Epirubicin—thyroid cancer	6.17e-05	0.00152	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—thyroid cancer	6.14e-05	0.00152	CcSEcCtD
Etoposide—Hypersensitivity—Sorafenib—thyroid cancer	5.9e-05	0.00146	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—thyroid cancer	5.76e-05	0.00142	CcSEcCtD
Etoposide—Asthenia—Sorafenib—thyroid cancer	5.75e-05	0.00142	CcSEcCtD
Etoposide—PTGS1—lymph node—thyroid cancer	5.73e-05	0.00642	CbGeAlD
Etoposide—Cardiac arrest—Epirubicin—thyroid cancer	5.73e-05	0.00141	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—thyroid cancer	5.71e-05	0.00141	CcSEcCtD
Etoposide—Pruritus—Sorafenib—thyroid cancer	5.67e-05	0.0014	CcSEcCtD
Etoposide—Diarrhoea—Sorafenib—thyroid cancer	5.48e-05	0.00135	CcSEcCtD
Etoposide—PTGS2—lymph node—thyroid cancer	5.48e-05	0.00613	CbGeAlD
Etoposide—ABCB1—thyroid gland—thyroid cancer	5.45e-05	0.00611	CbGeAlD
Etoposide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	5.42e-05	0.00134	CcSEcCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	5.32e-05	0.0529	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—thyroid cancer	5.32e-05	0.0529	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	5.32e-05	0.0529	CbGdCrCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—thyroid cancer	5.31e-05	0.00131	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—thyroid cancer	5.3e-05	0.00131	CcSEcCtD
Etoposide—Dizziness—Sorafenib—thyroid cancer	5.3e-05	0.00131	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—thyroid cancer	5.2e-05	0.00128	CcSEcCtD
Etoposide—Vomiting—Sorafenib—thyroid cancer	5.09e-05	0.00126	CcSEcCtD
Etoposide—Rash—Sorafenib—thyroid cancer	5.05e-05	0.00125	CcSEcCtD
Etoposide—Dermatitis—Sorafenib—thyroid cancer	5.04e-05	0.00124	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	5.02e-05	0.00124	CcSEcCtD
Etoposide—Headache—Sorafenib—thyroid cancer	5.02e-05	0.00124	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—thyroid cancer	4.94e-05	0.00122	CcSEcCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	4.92e-05	0.049	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	4.92e-05	0.049	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	4.92e-05	0.049	CbGdCrCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	4.91e-05	0.00121	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—thyroid cancer	4.87e-05	0.0012	CcSEcCtD
Etoposide—ABCB1—head—thyroid cancer	4.84e-05	0.00542	CbGeAlD
Etoposide—Dysphagia—Doxorubicin—thyroid cancer	4.81e-05	0.00119	CcSEcCtD
Etoposide—Nausea—Sorafenib—thyroid cancer	4.76e-05	0.00117	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—thyroid cancer	4.67e-05	0.00115	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—thyroid cancer	4.64e-05	0.00115	CcSEcCtD
Etoposide—Infestation—Epirubicin—thyroid cancer	4.64e-05	0.00115	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	4.6e-05	0.00114	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—thyroid cancer	4.57e-05	0.00113	CcSEcCtD
Etoposide—Renal failure—Epirubicin—thyroid cancer	4.56e-05	0.00113	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—thyroid cancer	4.55e-05	0.00112	CcSEcCtD
Etoposide—Jaundice—Epirubicin—thyroid cancer	4.52e-05	0.00112	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—thyroid cancer	4.52e-05	0.00112	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—thyroid cancer	4.5e-05	0.00111	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—thyroid cancer	4.39e-05	0.00108	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—thyroid cancer	4.33e-05	0.00107	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—thyroid cancer	4.32e-05	0.00107	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—thyroid cancer	4.29e-05	0.00106	CcSEcCtD
Etoposide—Infestation—Doxorubicin—thyroid cancer	4.29e-05	0.00106	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	4.26e-05	0.00105	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—thyroid cancer	4.22e-05	0.00104	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—thyroid cancer	4.21e-05	0.00104	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—thyroid cancer	4.18e-05	0.00103	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—thyroid cancer	4.18e-05	0.00103	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—thyroid cancer	4.14e-05	0.00102	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—thyroid cancer	4.11e-05	0.00102	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—thyroid cancer	4.08e-05	0.00101	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—thyroid cancer	4.06e-05	0.001	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—thyroid cancer	4.01e-05	0.000989	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—thyroid cancer	3.94e-05	0.000972	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—thyroid cancer	3.89e-05	0.000961	CcSEcCtD
Etoposide—Flushing—Epirubicin—thyroid cancer	3.87e-05	0.000954	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—thyroid cancer	3.87e-05	0.000954	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—thyroid cancer	3.83e-05	0.000946	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—thyroid cancer	3.81e-05	0.000939	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—thyroid cancer	3.78e-05	0.000933	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—thyroid cancer	3.78e-05	0.000932	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—thyroid cancer	3.76e-05	0.000929	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—thyroid cancer	3.75e-05	0.000927	CcSEcCtD
Etoposide—Chills—Epirubicin—thyroid cancer	3.74e-05	0.000922	CcSEcCtD
Etoposide—Alopecia—Epirubicin—thyroid cancer	3.68e-05	0.000908	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—thyroid cancer	3.64e-05	0.000899	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—thyroid cancer	3.6e-05	0.000889	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—thyroid cancer	3.58e-05	0.000883	CcSEcCtD
Etoposide—Flushing—Doxorubicin—thyroid cancer	3.58e-05	0.000883	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—thyroid cancer	3.55e-05	0.000876	CcSEcCtD
Etoposide—Back pain—Epirubicin—thyroid cancer	3.51e-05	0.000866	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—thyroid cancer	3.5e-05	0.000863	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—thyroid cancer	3.49e-05	0.00086	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—thyroid cancer	3.48e-05	0.000859	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—thyroid cancer	3.47e-05	0.000857	CcSEcCtD
Etoposide—Chills—Doxorubicin—thyroid cancer	3.46e-05	0.000854	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—thyroid cancer	3.41e-05	0.000841	CcSEcCtD
Etoposide—ABCB1—lymph node—thyroid cancer	3.39e-05	0.00379	CbGeAlD
Etoposide—Ill-defined disorder—Epirubicin—thyroid cancer	3.36e-05	0.00083	CcSEcCtD
Etoposide—Anaemia—Epirubicin—thyroid cancer	3.35e-05	0.000827	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—thyroid cancer	3.29e-05	0.000811	CcSEcCtD
Etoposide—Malaise—Epirubicin—thyroid cancer	3.27e-05	0.000807	CcSEcCtD
Etoposide—Vertigo—Epirubicin—thyroid cancer	3.26e-05	0.000804	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—thyroid cancer	3.25e-05	0.000801	CcSEcCtD
Etoposide—Back pain—Doxorubicin—thyroid cancer	3.25e-05	0.000801	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—thyroid cancer	3.23e-05	0.000796	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—thyroid cancer	3.19e-05	0.000787	CcSEcCtD
Etoposide—Cough—Epirubicin—thyroid cancer	3.16e-05	0.000781	CcSEcCtD
Etoposide—Convulsion—Epirubicin—thyroid cancer	3.14e-05	0.000775	CcSEcCtD
Etoposide—Hypertension—Epirubicin—thyroid cancer	3.13e-05	0.000773	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—thyroid cancer	3.11e-05	0.000768	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—thyroid cancer	3.1e-05	0.000765	CcSEcCtD
Etoposide—Chest pain—Epirubicin—thyroid cancer	3.09e-05	0.000762	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	3.07e-05	0.000757	CcSEcCtD
Etoposide—Discomfort—Epirubicin—thyroid cancer	3.05e-05	0.000753	CcSEcCtD
Etoposide—Malaise—Doxorubicin—thyroid cancer	3.03e-05	0.000747	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—thyroid cancer	3.01e-05	0.000744	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—thyroid cancer	3e-05	0.000741	CcSEcCtD
Etoposide—Confusional state—Epirubicin—thyroid cancer	2.98e-05	0.000736	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—thyroid cancer	2.96e-05	0.00073	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—thyroid cancer	2.95e-05	0.000728	CcSEcCtD
Etoposide—Infection—Epirubicin—thyroid cancer	2.94e-05	0.000726	CcSEcCtD
Etoposide—Cough—Doxorubicin—thyroid cancer	2.93e-05	0.000723	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—thyroid cancer	2.91e-05	0.000717	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—thyroid cancer	2.9e-05	0.000715	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—thyroid cancer	2.9e-05	0.000715	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—thyroid cancer	2.89e-05	0.000713	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—thyroid cancer	2.87e-05	0.000709	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—thyroid cancer	2.86e-05	0.000706	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—thyroid cancer	2.86e-05	0.000705	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	2.84e-05	0.0007	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—thyroid cancer	2.82e-05	0.000697	CcSEcCtD
Etoposide—Anorexia—Epirubicin—thyroid cancer	2.82e-05	0.000696	CcSEcCtD
Etoposide—Hypotension—Epirubicin—thyroid cancer	2.77e-05	0.000682	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—thyroid cancer	2.76e-05	0.000681	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—thyroid cancer	2.74e-05	0.000676	CcSEcCtD
Etoposide—Infection—Doxorubicin—thyroid cancer	2.72e-05	0.000671	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—thyroid cancer	2.68e-05	0.000662	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—thyroid cancer	2.67e-05	0.00066	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—thyroid cancer	2.66e-05	0.000656	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—thyroid cancer	2.66e-05	0.000656	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—thyroid cancer	2.65e-05	0.000653	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—thyroid cancer	2.64e-05	0.000651	CcSEcCtD
Etoposide—Somnolence—Epirubicin—thyroid cancer	2.63e-05	0.000649	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—thyroid cancer	2.61e-05	0.000644	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—thyroid cancer	2.57e-05	0.000635	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—thyroid cancer	2.56e-05	0.000631	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—thyroid cancer	2.55e-05	0.000631	CcSEcCtD
Etoposide—Fatigue—Epirubicin—thyroid cancer	2.55e-05	0.00063	CcSEcCtD
Etoposide—Constipation—Epirubicin—thyroid cancer	2.53e-05	0.000625	CcSEcCtD
Etoposide—Pain—Epirubicin—thyroid cancer	2.53e-05	0.000625	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—thyroid cancer	2.46e-05	0.000607	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—thyroid cancer	2.44e-05	0.000603	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—thyroid cancer	2.44e-05	0.000602	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—thyroid cancer	2.43e-05	0.000601	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—thyroid cancer	2.42e-05	0.000597	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—thyroid cancer	2.38e-05	0.000587	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	2.36e-05	0.000583	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—thyroid cancer	2.36e-05	0.000583	CcSEcCtD
Etoposide—Urticaria—Epirubicin—thyroid cancer	2.35e-05	0.00058	CcSEcCtD
Etoposide—Pain—Doxorubicin—thyroid cancer	2.34e-05	0.000578	CcSEcCtD
Etoposide—Constipation—Doxorubicin—thyroid cancer	2.34e-05	0.000578	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—thyroid cancer	2.34e-05	0.000577	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—thyroid cancer	2.34e-05	0.000577	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—thyroid cancer	2.26e-05	0.000557	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—thyroid cancer	2.24e-05	0.000553	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—thyroid cancer	2.18e-05	0.000538	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—thyroid cancer	2.18e-05	0.000537	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—thyroid cancer	2.16e-05	0.000534	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—thyroid cancer	2.16e-05	0.000534	CcSEcCtD
Etoposide—Asthenia—Epirubicin—thyroid cancer	2.12e-05	0.000524	CcSEcCtD
Etoposide—Pruritus—Epirubicin—thyroid cancer	2.09e-05	0.000517	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—thyroid cancer	2.02e-05	0.0005	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—thyroid cancer	2.02e-05	0.000498	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—thyroid cancer	1.96e-05	0.000485	CcSEcCtD
Etoposide—Dizziness—Epirubicin—thyroid cancer	1.96e-05	0.000483	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—thyroid cancer	1.94e-05	0.000478	CcSEcCtD
Etoposide—Vomiting—Epirubicin—thyroid cancer	1.88e-05	0.000464	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—thyroid cancer	1.87e-05	0.000462	CcSEcCtD
Etoposide—Rash—Epirubicin—thyroid cancer	1.87e-05	0.000461	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—thyroid cancer	1.86e-05	0.00046	CcSEcCtD
Etoposide—Headache—Epirubicin—thyroid cancer	1.85e-05	0.000458	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—thyroid cancer	1.81e-05	0.000447	CcSEcCtD
Etoposide—Nausea—Epirubicin—thyroid cancer	1.76e-05	0.000434	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—thyroid cancer	1.74e-05	0.00043	CcSEcCtD
Etoposide—Rash—Doxorubicin—thyroid cancer	1.73e-05	0.000426	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—thyroid cancer	1.72e-05	0.000426	CcSEcCtD
Etoposide—Headache—Doxorubicin—thyroid cancer	1.72e-05	0.000423	CcSEcCtD
Etoposide—Nausea—Doxorubicin—thyroid cancer	1.63e-05	0.000401	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.4e-05	0.00109	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	1.39e-05	0.00108	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	1.37e-05	0.00106	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NDUFA13—thyroid cancer	1.36e-05	0.00105	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CHST14—thyroid cancer	1.33e-05	0.00103	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	1.31e-05	0.00102	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.31e-05	0.00102	CbGpPWpGaD
Etoposide—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.3e-05	0.00101	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.29e-05	0.001	CbGpPWpGaD
Etoposide—PTGS2—Disease—TRIM24—thyroid cancer	1.29e-05	0.000997	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CHST14—thyroid cancer	1.28e-05	0.000989	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MINPP1—thyroid cancer	1.27e-05	0.000982	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—HPGD—thyroid cancer	1.26e-05	0.000978	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.26e-05	0.000976	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—HPGD—thyroid cancer	1.22e-05	0.000943	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.21e-05	0.000942	CbGpPWpGaD
Etoposide—PTGS2—Disease—CHST14—thyroid cancer	1.21e-05	0.000938	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.2e-05	0.000928	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MINPP1—thyroid cancer	1.19e-05	0.000925	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.19e-05	0.000923	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	1.18e-05	0.000917	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TERT—thyroid cancer	1.15e-05	0.00089	CbGpPWpGaD
Etoposide—PTGS2—Disease—TRIM33—thyroid cancer	1.15e-05	0.000889	CbGpPWpGaD
Etoposide—ABCC1—Disease—TCF7L1—thyroid cancer	1.14e-05	0.000884	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.13e-05	0.00088	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.13e-05	0.000876	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.12e-05	0.000872	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.12e-05	0.000866	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—thyroid cancer	1.11e-05	0.000864	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.08e-05	0.00084	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—SLC5A5—thyroid cancer	1.08e-05	0.000838	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NDUFA13—thyroid cancer	1.08e-05	0.000835	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—HPGD—thyroid cancer	1.07e-05	0.00083	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	1.05e-05	0.000811	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000811	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.04e-05	0.000804	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MINPP1—thyroid cancer	1.03e-05	0.000799	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—HPGD—thyroid cancer	1.03e-05	0.000797	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	1.02e-05	0.000789	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NDUFA13—thyroid cancer	1.01e-05	0.000786	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CHST14—thyroid cancer	1.01e-05	0.000785	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.01e-05	0.000785	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.01e-05	0.000783	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.86e-06	0.000765	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.82e-06	0.000762	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—RXRA—thyroid cancer	9.75e-06	0.000757	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	9.68e-06	0.000751	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CHST14—thyroid cancer	9.53e-06	0.000739	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CHST14—thyroid cancer	9.51e-06	0.000738	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.49e-06	0.000736	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.38e-06	0.000727	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	9.32e-06	0.000723	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—RXRA—thyroid cancer	9.07e-06	0.000704	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MINPP1—thyroid cancer	8.98e-06	0.000696	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—TPR—thyroid cancer	8.91e-06	0.000691	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PRKAR1A—thyroid cancer	8.77e-06	0.00068	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NDUFA13—thyroid cancer	8.76e-06	0.00068	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	8.64e-06	0.000671	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.52e-06	0.000661	CbGpPWpGaD
Etoposide—ABCC1—Disease—TPR—thyroid cancer	8.34e-06	0.000647	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.34e-06	0.000647	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.25e-06	0.00064	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CHST14—thyroid cancer	8.24e-06	0.000639	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—thyroid cancer	8.22e-06	0.000638	CbGpPWpGaD
Etoposide—ABCC1—Disease—PRKAR1A—thyroid cancer	8.2e-06	0.000636	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HPGD—thyroid cancer	8.16e-06	0.000633	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.95e-06	0.000616	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	7.92e-06	0.000614	CbGpPWpGaD
Etoposide—ABCC1—Disease—MEN1—thyroid cancer	7.84e-06	0.000608	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HPGD—thyroid cancer	7.68e-06	0.000596	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HPGD—thyroid cancer	7.66e-06	0.000595	CbGpPWpGaD
Etoposide—PTGS2—Disease—TCF7L1—thyroid cancer	7.64e-06	0.000593	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NDUFA13—thyroid cancer	7.63e-06	0.000592	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	7.53e-06	0.000584	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	7.41e-06	0.000575	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TPR—thyroid cancer	7.24e-06	0.000562	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CHST14—thyroid cancer	7.18e-06	0.000557	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTEN—thyroid cancer	7.17e-06	0.000556	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MINPP1—thyroid cancer	7.16e-06	0.000556	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	7.12e-06	0.000553	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.11e-06	0.000552	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.09e-06	0.00055	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	7.09e-06	0.00055	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TPR—thyroid cancer	6.98e-06	0.000542	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.98e-06	0.000541	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	6.89e-06	0.000534	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PRKAR1A—thyroid cancer	6.87e-06	0.000533	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	6.86e-06	0.000533	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—SLC5A5—thyroid cancer	6.67e-06	0.000518	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HPGD—thyroid cancer	6.64e-06	0.000515	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND1—thyroid cancer	6.63e-06	0.000514	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.62e-06	0.000513	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.56e-06	0.000509	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.25e-06	0.000485	CbGpPWpGaD
Etoposide—ABCC1—Disease—CALCA—thyroid cancer	6.24e-06	0.000484	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.23e-06	0.000483	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TPR—thyroid cancer	6.14e-06	0.000477	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NDUFA13—thyroid cancer	6.09e-06	0.000473	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PRKAR1A—thyroid cancer	6.04e-06	0.000469	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TPR—thyroid cancer	5.9e-06	0.000458	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PRKAR1A—thyroid cancer	5.81e-06	0.000451	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HPGD—thyroid cancer	5.78e-06	0.000449	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CHST14—thyroid cancer	5.73e-06	0.000444	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PPARG—thyroid cancer	5.73e-06	0.000444	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDK1—thyroid cancer	5.65e-06	0.000438	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—RXRA—thyroid cancer	5.6e-06	0.000435	CbGpPWpGaD
Etoposide—PTGS2—Disease—TPR—thyroid cancer	5.6e-06	0.000434	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.58e-06	0.000433	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.53e-06	0.000429	CbGpPWpGaD
Etoposide—PTGS2—Disease—PRKAR1A—thyroid cancer	5.5e-06	0.000427	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.45e-06	0.000423	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—SLC5A5—thyroid cancer	5.42e-06	0.000421	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.38e-06	0.000418	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.31e-06	0.000412	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.27e-06	0.000409	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.26e-06	0.000408	CbGpPWpGaD
Etoposide—PTGS2—Disease—MEN1—thyroid cancer	5.26e-06	0.000408	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—SLC5A5—thyroid cancer	5.23e-06	0.000406	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.04e-06	0.000391	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.9e-06	0.00038	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.87e-06	0.000378	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.7e-06	0.000365	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TPR—thyroid cancer	4.69e-06	0.000364	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.69e-06	0.000363	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HPGD—thyroid cancer	4.62e-06	0.000358	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PRKAR1A—thyroid cancer	4.61e-06	0.000358	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—SLC5A5—thyroid cancer	4.6e-06	0.000357	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—RXRA—thyroid cancer	4.55e-06	0.000353	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRG1—thyroid cancer	4.53e-06	0.000352	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—thyroid cancer	4.51e-06	0.00035	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.46e-06	0.000346	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CHST14—thyroid cancer	4.42e-06	0.000343	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC5A5—thyroid cancer	4.42e-06	0.000343	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TPR—thyroid cancer	4.41e-06	0.000342	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TPR—thyroid cancer	4.4e-06	0.000342	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—RXRA—thyroid cancer	4.39e-06	0.000341	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—thyroid cancer	4.37e-06	0.000339	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	4.34e-06	0.000337	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	4.33e-06	0.000336	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.27e-06	0.000331	CbGpPWpGaD
Etoposide—PTGS2—Disease—CALCA—thyroid cancer	4.19e-06	0.000325	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.18e-06	0.000324	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.14e-06	0.000321	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—thyroid cancer	4.13e-06	0.000321	CbGpPWpGaD
Etoposide—ABCC1—Disease—TERT—thyroid cancer	4.07e-06	0.000316	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.96e-06	0.000307	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTEN—thyroid cancer	3.93e-06	0.000305	CbGpPWpGaD
Etoposide—ABCC1—Disease—HIF1A—thyroid cancer	3.89e-06	0.000302	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—RXRA—thyroid cancer	3.86e-06	0.0003	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TPR—thyroid cancer	3.81e-06	0.000296	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDK1—thyroid cancer	3.79e-06	0.000294	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.75e-06	0.000291	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.75e-06	0.000291	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.74e-06	0.00029	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—RXRA—thyroid cancer	3.71e-06	0.000288	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.61e-06	0.00028	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPGD—thyroid cancer	3.56e-06	0.000276	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PPARG—thyroid cancer	3.54e-06	0.000275	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC5A5—thyroid cancer	3.51e-06	0.000272	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.4e-06	0.000264	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TPR—thyroid cancer	3.32e-06	0.000258	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.32e-06	0.000258	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC5A5—thyroid cancer	3.3e-06	0.000256	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC5A5—thyroid cancer	3.3e-06	0.000256	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.27e-06	0.000254	CbGpPWpGaD
Etoposide—ABCC1—Disease—BRAF—thyroid cancer	3.22e-06	0.00025	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRG1—thyroid cancer	3.04e-06	0.000236	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—RXRA—thyroid cancer	2.95e-06	0.000229	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—thyroid cancer	2.88e-06	0.000223	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.87e-06	0.000222	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.85e-06	0.000221	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.8e-06	0.000218	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—thyroid cancer	2.78e-06	0.000216	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—RXRA—thyroid cancer	2.77e-06	0.000215	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—thyroid cancer	2.77e-06	0.000215	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—RXRA—thyroid cancer	2.77e-06	0.000215	CbGpPWpGaD
Etoposide—PTGS2—Disease—TERT—thyroid cancer	2.73e-06	0.000212	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.67e-06	0.000208	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TPR—thyroid cancer	2.65e-06	0.000206	CbGpPWpGaD
Etoposide—PTGS2—Disease—HIF1A—thyroid cancer	2.61e-06	0.000203	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.61e-06	0.000202	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—thyroid cancer	2.6e-06	0.000202	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.49e-06	0.000193	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—thyroid cancer	2.44e-06	0.000189	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—thyroid cancer	2.43e-06	0.000188	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—RXRA—thyroid cancer	2.4e-06	0.000186	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.36e-06	0.000183	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—thyroid cancer	2.34e-06	0.000182	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.33e-06	0.000181	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—thyroid cancer	2.27e-06	0.000176	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—thyroid cancer	2.26e-06	0.000176	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—thyroid cancer	2.26e-06	0.000176	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—thyroid cancer	2.18e-06	0.000169	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—thyroid cancer	2.16e-06	0.000168	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—RXRA—thyroid cancer	2.09e-06	0.000162	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TPR—thyroid cancer	2.05e-06	0.000159	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—thyroid cancer	2.03e-06	0.000157	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.01e-06	0.000156	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.99e-06	0.000154	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—thyroid cancer	1.97e-06	0.000153	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—thyroid cancer	1.92e-06	0.000149	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—thyroid cancer	1.9e-06	0.000148	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—thyroid cancer	1.86e-06	0.000144	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.86e-06	0.000144	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—thyroid cancer	1.84e-06	0.000143	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—thyroid cancer	1.75e-06	0.000136	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—thyroid cancer	1.75e-06	0.000136	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—thyroid cancer	1.74e-06	0.000135	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—thyroid cancer	1.67e-06	0.00013	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—RXRA—thyroid cancer	1.67e-06	0.000129	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.62e-06	0.000126	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—thyroid cancer	1.61e-06	0.000125	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.53e-06	0.000119	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—thyroid cancer	1.52e-06	0.000118	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—thyroid cancer	1.51e-06	0.000117	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—thyroid cancer	1.48e-06	0.000115	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—thyroid cancer	1.4e-06	0.000109	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.38e-06	0.000107	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.38e-06	0.000107	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—thyroid cancer	1.36e-06	0.000106	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—thyroid cancer	1.32e-06	0.000102	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—thyroid cancer	1.31e-06	0.000102	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—RXRA—thyroid cancer	1.29e-06	9.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—thyroid cancer	1.28e-06	9.9e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—thyroid cancer	1.2e-06	9.32e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—thyroid cancer	1.2e-06	9.3e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.19e-06	9.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—thyroid cancer	1.17e-06	9.08e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—thyroid cancer	1.14e-06	8.82e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—thyroid cancer	1.1e-06	8.51e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—thyroid cancer	1.05e-06	8.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—thyroid cancer	1.04e-06	8.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—thyroid cancer	1.04e-06	8.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—thyroid cancer	9.95e-07	7.72e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—thyroid cancer	9.65e-07	7.48e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—thyroid cancer	9.27e-07	7.19e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—thyroid cancer	9.05e-07	7.02e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—thyroid cancer	8.79e-07	6.82e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.28e-07	6.43e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—thyroid cancer	8.13e-07	6.31e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—thyroid cancer	7.36e-07	5.71e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—thyroid cancer	7.22e-07	5.61e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—thyroid cancer	6.93e-07	5.37e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—thyroid cancer	6.91e-07	5.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.39e-07	4.96e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—thyroid cancer	5.99e-07	4.64e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—thyroid cancer	5.58e-07	4.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—thyroid cancer	5.22e-07	4.05e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—thyroid cancer	4.16e-07	3.23e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—thyroid cancer	3.21e-07	2.49e-05	CbGpPWpGaD
